NovaBridge Biosciences (NBP) Total liabilities 2021–2025
NovaBridge Biosciences (NBP) total liabilities at each fiscal year-end, per SEC filings.
$126.3MFY2025 · since FY2021: $96.0M → $126.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $126.3M | -25.1% |
| FY2024 | $168.7M | +3.2% |
| FY2023 | $163.5M | +50.9% |
| FY2022 | $108.3M | +12.9% |
| FY2021 | $96.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice